Janelle Johnson

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

D. Tyrrell, M. Houghton, M. Logan, 2019, Journal of Virology.

Determination of Pharmacokinetics and Pharmacodynamics of Lamivudine After Highdoses in Duck Hepatitis B Virus-Infected Pekin Ducks

M. Houghton, M. Fakheri, D. Santer, 2018 .

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1

K. Pabbaraju, E. Arutyunova, Justin Shields, 2021, bioRxiv.

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG

M. Houghton, M. Law, M. Logan, 2016, Journal of Virology.

Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine

D. Tyrrell, M. Houghton, E. Dudek, 2018, Journal of Virology.

Role of the E2 hypervariable region (HVR1) in the immunogenicity of a 1 recombinant HCV vaccine

M. Houghton, E. Dudek, M. Logan, 2018 .